Found 13 matching trials
Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission PHASE2 The primary aim of this innovative immunotherapeutic study is to determine ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma PHASE2 Dendritic cell therapy is a promising strategy for adjuvant cancer therapy ...
Show More Location
University Hospital Antwerp
Learn More & Join Trial
Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission PHASE1 RATIONALE: Vaccines made from a patient's white blood cells (dendritic cell...
Show More Location
Antwerp University Hospital/Center for Cellular Therapy and Regenerative Medicine
Learn More & Join Trial
Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma PHASE1 This study is being done to see if the investigators can help the immune sy...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients PHASE1 Dendritic cells (DCs) are the professional antigen-presenting cells of the ...
Show More Location
Radboud University Nijmegen Medical Center, dept. of Medical Oncology
Learn More & Join Trial
A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV Melanoma PHASE1 This phase I study plan is divided in the following four phases:
* Eligibi...
Show More Learn More & Join Trial
DC Vaccination for Postremission Therapy in AML PHASE1 The aim of this study is to determine the feasibility and safety of an auto...
Show More Location
Hospital of the University of Munich, LMU; Department od Medicine III
Learn More & Join Trial
Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia PHASE1 The main objective of this work is to conduct a clinical study for the deve...
Show More Location
Hematology and Transfusion Medicine Center
Learn More & Join Trial
Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients PHASE1 1. Rationale
Immunotherapy applying ex vivo generated and tumor antigen...
Show More Location
Radboud University Nijmegen Medical Centre
Learn More & Join Trial
CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation PHASE1 The purpose of this study is to see if the investigator can help the immune...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial